Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 鳞状细胞(Carcinoma, Squamous Cell);顺铂(Cisplatin);综合疗法(Combined Modality Therapy);用药计划表(Drug Administration Schedule);氟尿嘧啶(Fluorouracil);基因, p53(Genes, p53);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);喹唑啉类(Quinazolines);受体, 生长因子(Receptors, Growth Factor);受体, 有丝分裂原(Receptors, Mitogen);受体, 血管内皮生长因子(Receptors, Vascular Endothelial Growth Factor);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1038/sj.bjc.6600103
PMID
11875748
发布时间
2022-03-21
- 浏览16

British journal of cancer
819-27页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文